반려동물 일반의약품 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Pet OTC Medication Market size is expected to reach USD 17.87 Billion in 2034 from USD 10.45 Billion (2025) growing at a CAGR of 6.15% during 2026-2034.

The global pet OTC medication market has been growing steadily due to increasing pet ownership and rising awareness about animal health. Over-the-counter medications for pets are commonly used to treat minor illnesses, parasites, allergies, and digestive issues without requiring a prescription. Pet owners are increasingly investing in preventive healthcare products to maintain their pets' well-being.

Several factors are driving market growth, including the growing trend of pet humanization and increasing spending on pet care products. The availability of a wide range of OTC medications in pet stores, veterinary clinics, and online platforms has made it easier for pet owners to access treatments. Additionally, advancements in veterinary pharmaceuticals have improved the effectiveness and safety of these medications.

The market is expected to continue expanding as pet ownership rises globally. Innovations in pet healthcare products and the development of natural and herbal medications are gaining popularity among pet owners. The growth of e-commerce platforms and online veterinary services will further increase accessibility to OTC medications for pets.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Medication Type

• Flea And Tick Control
• Dewormers & Parasiticides
• Pain Relievers & Allergy Medications
• Skin And Coat Care
• Dental Care
• Nutritional Supplements
• Behavioral & Anxiety Relief Medications
• Other Medication Types

By Pet Type

• Dogs
• Cats
• Birds
• Fishes & Reptiles
• Other Pet Types

By Dosage Form

• Chews & Treats
• Capsules
• Sprays
• Ointments
• Other Dosage Forms

By Distribution Channel

• Veterinary Pharmacies
• Pet Specialty Stores
• Online Retailers
• Other Distribution Channels

COMPANIES PROFILED

• AdvaCare Pharma, Bimeda, Boehringer Ingelheim International, Ceva Sante Animale, Dechra, Elanco Animal Health, Heska Corporation, Merck Co, Norbrook, Nutramax Laboratories Consumer Care, PetIQ, Phibro Animal Health, Vetenex Animal Health, Vetoquinol, Virbac, Zoetis
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PET OTC MEDICATION MARKET: BY MEDICATION TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Medication Type
• 4.2. Flea And Tick Control Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dewormers & Parasiticides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pain Relievers & Allergy Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Skin And Coat Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Dental Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Nutritional Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Behavioral & Anxiety Relief Medications Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Other Medication Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PET OTC MEDICATION MARKET: BY PET TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Pet Type
• 5.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Birds Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Fishes & Reptiles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Pet Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PET OTC MEDICATION MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dosage Form
• 6.2. Chews & Treats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Capsules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Sprays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PET OTC MEDICATION MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pet Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Online Retailers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PET OTC MEDICATION MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Medication Type
  • 8.2.2 By Pet Type
  • 8.2.3 By Dosage Form
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Medication Type
  • 8.3.2 By Pet Type
  • 8.3.3 By Dosage Form
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Medication Type
  • 8.4.2 By Pet Type
  • 8.4.3 By Dosage Form
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Medication Type
  • 8.5.2 By Pet Type
  • 8.5.3 By Dosage Form
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Medication Type
  • 8.6.2 By Pet Type
  • 8.6.3 By Dosage Form
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PET OTC MEDICATION INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AdvaCare Pharma
  • 10.2.2 Bimeda
  • 10.2.3 Boehringer Ingelheim International
  • 10.2.4 Ceva Sante Animale
  • 10.2.5 Dechra
  • 10.2.6 Elanco Animal Health
  • 10.2.7 Heska Corporation
  • 10.2.8 Merck & Co
  • 10.2.9 Norbrook
  • 10.2.10 Nutramax Laboratories Consumer Care
  • 10.2.11 PetIQ
  • 10.2.12 Phibro Animal Health
  • 10.2.13 Vetenex Animal Health
  • 10.2.14 Vetoquinol
  • 10.2.15 Virbac
  • 10.2.16 Zoetis